Clinical Trial Update: Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intrauterine misoprostol to IV oxytocin infusion for cesarean delivery in the context of postpartum hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• misoprostol (intrauterine) (misoprostol)
• oxytocin (intravenous infusion) (oxytocin)

Snippet

Sponsor: Assiut University | Conditions: Post Partum Hemorrhage | Phase 3 | Status: COMPLETED